Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
作者信息
Ram C V, Holland O B, Kaplan N M
出版信息
J Clin Pharmacol. 1981 Nov-Dec;21(11):484-7. doi: 10.1002/j.1552-4604.1981.tb05654.x.
Abstract
摘要
相似文献
1
Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.保钾利尿剂阿米洛利减轻利尿剂诱发的低钾血症。
J Clin Pharmacol. 1981 Nov-Dec;21(11):484-7. doi: 10.1002/j.1552-4604.1981.tb05654.x.
2
Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.氨氯吡咪和螺内酯对噻嗪类药物所致低钾血症高血压患者保钾作用的比较。
Lancet. 1973 Dec 8;2(7841):1288-91. doi: 10.1016/s0140-6736(73)92869-9.
3
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.新型保钾利尿剂氨氯吡咪和转换酶抑制剂MK-421在预防原发性和继发性醛固酮增多症相关低钾血症中的治疗应用。
Clin Exp Hypertens A. 1983;5(6):779-801. doi: 10.3109/10641968309081808.
4
Potassium conservation with amiloride/hydrochlorothiazide ("Moduret') in thiazide-induced hypokalaemia in hypertension.氨氯吡咪/氢氯噻嗪（“Moduret”）对高血压患者噻嗪类药物所致低钾血症的钾保留作用
Curr Med Res Opin. 1982;8(2):120-7. doi: 10.1185/03007998209109767.
5
Maintenance of potassium balance during diuretic therapy.利尿治疗期间钾平衡的维持。
Acta Med Scand. 1979;205(4):319-24. doi: 10.1111/j.0954-6820.1979.tb06056.x.
6
Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.口服氯化钾和氨苯蝶啶治疗氢氯噻嗪引起的钾丢失。
Clin Pharmacol Ther. 1984 Oct;36(4):431-5. doi: 10.1038/clpt.1984.200.
7
[Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].[高血压患者的治疗。阿米洛利在保钾利尿治疗中的价值]
Nouv Presse Med. 1972 Sep 16;1(32):2121-2.
8
9
[Clinical testing of a new potassium-saving diuretic for the treatment of hypertension].一种新型保钾利尿剂治疗高血压的临床试验
Munch Med Wochenschr. 1973 Dec 7;115(49):2249-50.
10
Hypokalemia in thiazide-treated systemic hypertension.噻嗪类药物治疗的系统性高血压中的低钾血症。
Am J Cardiol. 1986 Jul 31;58(2):18A-21A. doi: 10.1016/0002-9149(86)90878-7.
Zotero 插件